mRNA pioneer Moderna has reported total revenue of $18.5 billion for the full year 2021, compared to $803 million in 2020. Product sales were $17.7 billion from sales of 807 million doses of the company’s Spikevax COVID-19 vaccine. Net income for 2021 was $12.2 billion, compared to a net loss of $747 million in 2020. […]

Eli Lilly has announced the launch of the Lilly Institute for Genetic Medicine and an investment of approximately $700 million to establish a state-of-the-art facility at a new site in the Boston Seaport. This investment – part of the company’s strategy to advance RNA based therapeutics – builds on the 2020 acquisition and rapid expansion of Prevail Therapeutics, a […]

Cambridge-based Agios Pharmaceuticals has announced that the FDA has approved Pyrukynd in the U.S. for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency, a rare, debilitating, chronic hemolytic anemia. Pyrukynd is a first-in-class, oral PK activator and the first approved disease-modifying therapy for this disease. The drug was reviewed by the FDA under Priority Review and […]

Waltham-based Arrakis Therapeutics has announced a research collaboration with drug giant Amgen. Arrakis is building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines focused on cancer and genetically validated targets in other disease areas. Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders […]

Sanofi has unveiled a new corporate brand and logo that supports the modernization and transformation the company launched in December 2019. Current business units Sanofi Pasteur and Sanofi Genzyme, focused on vaccines and specialty care respectively, and all other acquired brands, will be united under the singular Sanofi name and brand. According to the company, […]

Cambridge-based Vericel, a leader in advanced therapies for the sports medicine and severe burn care markets, has entered into a long-term lease agreement for a new state-of-the-art advanced cell therapy manufacturing and corporate headquarters facility at the Network Drive campus at Northwest Park in Burlington. The new facility, which will include approximately 125,000 square feet […]

The state’s biopharma companies attracted record-breaking VC funding last year according to the newly-released MassBio 2021 Massachusetts Biopharma Funding Report. See the report’s key findings and conclusions below, then visit the MassBio website to download the full report. Following on 2020’s record breaking year, biopharma companies headquartered in Massachusetts received $13.66 billion in venture capital […]